A ALIMENTARY TRACT AND METABOLISM
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
C CARDIOVASCULAR SYSTEM
|
|
D DERMATOLOGICALS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
J ANTIINFECTIVES FOR SYSTEMIC USE
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
L01 ANTINEOPLASTIC AGENTS
|
L01A ALKYLATING AGENTS
|
L01B ANTIMETABOLITES
|
L01BA Folic acid analogues
|
L01BA01 Methotrexate [DG:DG00681]
|
D00142 Methotrexate (JP18/USP/INN) <JP/US>
D02115 Methotrexate sodium <US>
|
L01BA03 Raltitrexed
|
L01BA04 Pemetrexed [DG:DG00682]
|
L01BA05 Pralatrexate
|
L01BB Purine analogues
|
L01BC Pyrimidine analogues
|
L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
|
L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
|
L01E PROTEIN KINASE INHIBITORS
|
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
|
L01X OTHER ANTINEOPLASTIC AGENTS
|
L02 ENDOCRINE THERAPY
|
L03 IMMUNOSTIMULANTS
|
L04 IMMUNOSUPPRESSANTS
|
L04A IMMUNOSUPPRESSANTS
|
L04AA Selective immunosuppressants
|
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors [DG:DG01936]
|
L04AC Interleukin inhibitors [DG:DG02019]
|
L04AD Calcineurin inhibitors [DG:DG03129]
|
L04AE Sphingosine-1-phosphate (S1P) receptor modulators
|
L04AF Janus-associated kinase (JAK) inhibitors
|
L04AG Monoclonal antibodies
|
L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors
|
L04AJ Complement inhibitors
|
L04AK Dihydroorotate dehydrogenase (DHODH) inhibitors
|
L04AX Other immunosuppressants
|
L04AX01 Azathioprine [DG:DG00743]
|
L04AX02 Thalidomide
|
L04AX03 Methotrexate [DG:DG00681]
|
D00142 Methotrexate (JP18/USP/INN) <JP/US>
D02115 Methotrexate sodium <US>
|
L04AX04 Lenalidomide [DG:DG00744]
|
L04AX05 Pirfenidone
|
L04AX06 Pomalidomide
|
L04AX07 Dimethyl fumarate
|
L04AX08 Darvadstrocel
|
L04AX09 Diroximel fumarate
|
|
M MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|